Proximagen Neuroscience

Contact
proximagen.com
+442078486938

Proximagen Neuroscience plc

Hodgkin Building, Guy's Campus, King's College London
SE1 1UL London
United Kingdom
+442078486938
proximagen.com
Contact
Profile News
Contact

About Proximagen Neuroscience

Proximagen is a biopharmaceutical company focused on the development and commercialisation of novel therapeutics for diseases of the central nervous system. Its current lead programmes aim to improve the quality of life for patients suffering from neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.

Read more about Proximagen Neuroscience
Facts about Proximagen Neuroscience
  • Industry : Pharma

News about Proximagen Neuroscience

Proximagen Neuroscience

08-Jul-2010 | science

Proximagen enters into a Collaboration Agreement with the NIH for a Phase II clinical trial on naluzotan

Proximagen Group plc announced that it has signed a Collaboration Research and Development Agreement (CRADA) with the National Institute of Neurological ...

Read news
Proximagen Neuroscience

14-Apr-2010 | business & finance

Proximagen sublicenses rights to tonabersat in North America

Proximagen Neuroscience plc announced that it has signed a development, license and sub-license agreement with Upsher-Smith Laboratories Inc.in relation ...

Read news
Proximagen Neuroscience

15-Mar-2010 | research and development

Proximagen announces positive efficacy results in NIH epilepsy studies

Proximagen Neuroscience plc announced headline results from the successful completion of a year-long non-clinical testing programme undertaken by the ...

Read news
Proximagen Neuroscience

25-Nov-2009 | business & finance

Biovitrum Completes Divestiture of Cambridge Biotechnology

Biovitrum AB announced that it has completed the divestiture of its wholly-owned subsidiary Cambridge Biotechnology Ltd (CBT), and the sale of certain drug ...

Read news
Show more news about Proximagen Neuroscience

Here you will find Proximagen Neuroscience plc